These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 19853925

  • 21. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ, Brownfoot FC, Hastie R, Chand A, Cannon P, Deo M, Tuohey L, Whitehead C, Hannan NJ, Tong S.
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [Abstract] [Full Text] [Related]

  • 22. Molecular mechanisms of preeclampsia.
    Mutter WP, Karumanchi SA.
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [Abstract] [Full Text] [Related]

  • 23. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B, Thornton C, Tooher J, Ogle R, Lim S, Makris A, Hennessy A.
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [Abstract] [Full Text] [Related]

  • 24. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
    Aggarwal S, Sunderland N, Thornton C, Xu B, Hennessy A, Makris A.
    Am J Obstet Gynecol; 2017 Feb; 216(2):170.e1-170.e8. PubMed ID: 27793555
    [Abstract] [Full Text] [Related]

  • 25. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A.
    Circulation; 2007 Apr 03; 115(13):1789-97. PubMed ID: 17389265
    [Abstract] [Full Text] [Related]

  • 26. Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors.
    Hirashima C, Ohkuchi A, Takahashi K, Suzuki H, Yoshida M, Ohmaru T, Eguchi K, Ariga H, Matsubara S, Suzuki M.
    Hypertens Res; 2011 Feb 03; 34(2):212-7. PubMed ID: 21048778
    [Abstract] [Full Text] [Related]

  • 27. Preeclampsia--a placenta developmental biology perspective.
    Goldman-Wohl D, Yagel S.
    J Reprod Immunol; 2009 Nov 03; 82(2):96-9. PubMed ID: 19586664
    [Abstract] [Full Text] [Related]

  • 28. Preeclampsia: new insights.
    Shah DM.
    Curr Opin Nephrol Hypertens; 2007 May 03; 16(3):213-20. PubMed ID: 17420664
    [Abstract] [Full Text] [Related]

  • 29. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
    Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y, Momoeda M, Kozuma S, Taketani Y.
    Endocrinology; 2004 Nov 03; 145(11):4838-45. PubMed ID: 15284201
    [Abstract] [Full Text] [Related]

  • 30. Relationships among maternal nutrient intake and placental biomarkers during the 1st trimester in low-income women.
    Fowles ER, Walker LO, Marti CN, Ruiz RJ, Wommack J, Bryant M, Kim S, Timmerman GM.
    Arch Gynecol Obstet; 2012 Apr 03; 285(4):891-9. PubMed ID: 22234787
    [Abstract] [Full Text] [Related]

  • 31. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
    Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Dec 03; 32(7):871-6. PubMed ID: 18814185
    [Abstract] [Full Text] [Related]

  • 32. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
    Munaut C, Lorquet S, Pequeux C, Blacher S, Berndt S, Frankenne F, Foidart JM.
    Hum Reprod; 2008 Jun 03; 23(6):1407-15. PubMed ID: 18413304
    [Abstract] [Full Text] [Related]

  • 33. Maternal and foetal angiogenic imbalance in congenital heart defects.
    Llurba E, Sánchez O, Ferrer Q, Nicolaides KH, Ruíz A, Domínguez C, Sánchez-de-Toledo J, García-García B, Soro G, Arévalo S, Goya M, Suy A, Pérez-Hoyos S, Alijotas-Reig J, Carreras E, Cabero L.
    Eur Heart J; 2014 Mar 03; 35(11):701-7. PubMed ID: 24159191
    [Abstract] [Full Text] [Related]

  • 34. Angiogenic balance (sFlt-1/PlGF) and preeclampsia.
    Lecarpentier E, Tsatsaris V.
    Ann Endocrinol (Paris); 2016 Jun 03; 77(2):97-100. PubMed ID: 27130072
    [Abstract] [Full Text] [Related]

  • 35. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'anna R.
    Acta Obstet Gynecol Scand; 2008 Jun 03; 87(8):837-42. PubMed ID: 18607829
    [Abstract] [Full Text] [Related]

  • 36. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA.
    J Clin Endocrinol Metab; 2005 Aug 03; 90(8):4895-903. PubMed ID: 15886253
    [Abstract] [Full Text] [Related]

  • 37. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S, Kaitu'u-Lino TJ, Onda K, Beard S, Hastie R, Binder NK, Cluver C, Tuohey L, Whitehead C, Brownfoot F, De Silva M, Hannan NJ.
    Hypertension; 2015 Nov 03; 66(5):1073-81. PubMed ID: 26324507
    [Abstract] [Full Text] [Related]

  • 38. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis.
    Tal R.
    Biol Reprod; 2012 Jun 03; 87(6):134. PubMed ID: 23034156
    [Abstract] [Full Text] [Related]

  • 39. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A, Rana S, Karumanchi SA.
    Physiology (Bethesda); 2009 Jun 03; 24():147-58. PubMed ID: 19509125
    [Abstract] [Full Text] [Related]

  • 40. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
    Buhimschi CS, Baumbusch MA, Dulay AT, Lee S, Wehrum M, Zhao G, Bahtiyar MO, Pettker CM, Ali UA, Funai EF, Buhimschi IA.
    BJOG; 2010 Feb 03; 117(3):321-30. PubMed ID: 19943826
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.